207 related articles for article (PubMed ID: 31998654)
1. CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer.
Yu S; Yi M; Xu L; Qin S; Li A; Wu K
Front Oncol; 2019; 9():1515. PubMed ID: 31998654
[No Abstract] [Full Text] [Related]
2. DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
Liu Q; Li A; Yu S; Qin S; Han N; Pestell RG; Han X; Wu K
J Hematol Oncol; 2018 Apr; 11(1):53. PubMed ID: 29636079
[TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.
Zhang X; Niu M; Li T; Wu Y; Gao J; Yi M; Wu K
Biomark Res; 2023 Dec; 11(1):106. PubMed ID: 38093319
[TBL] [Abstract][Full Text] [Related]
4. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.
Han N; Yuan X; Wu H; Xu H; Chu Q; Guo M; Yu S; Chen Y; Wu K
Oncotarget; 2015 Mar; 6(8):5877-88. PubMed ID: 25788272
[TBL] [Abstract][Full Text] [Related]
5. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
Pan GF; Zhou XF; Zhao JP
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
[No Abstract] [Full Text] [Related]
7. Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.
Qin G; Lian J; Huang L; Zhao Q; Liu S; Zhang Z; Chen X; Yue D; Li L; Li F; Wang L; Umansky V; Zhang B; Yang S; Zhang Y
Oncoimmunology; 2018; 7(7):e1442167. PubMed ID: 29900050
[No Abstract] [Full Text] [Related]
8. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
9. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
Gu L; Yao Y; Chen Z
Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of CXCL5 in non-small cell lung cancer.
Wu K; Yu S; Liu Q; Bai X; Zheng X; Wu K
Onco Targets Ther; 2017; 10():5561-5573. PubMed ID: 29200871
[TBL] [Abstract][Full Text] [Related]
11. MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.
Zhang Q; Yuan Y; Cui J; Xiao T; Jiang D
J Cancer; 2015; 6(2):184-91. PubMed ID: 25653720
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.
Ma GY; Shi S; Zhang YR; Guo ZB; Bai WW; Zhang ZG
Oncol Lett; 2022 Nov; 24(5):412. PubMed ID: 36245823
[TBL] [Abstract][Full Text] [Related]
13. Role of DACH1 on Proliferation, Invasion, and Apoptosis in Human Lung Adenocarcinoma Cells.
Yu J; Jiang P; Zhao K; Chen Z; Zuo T; Chen B
Curr Mol Med; 2021; 21(9):806-811. PubMed ID: 33463463
[TBL] [Abstract][Full Text] [Related]
14. Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration.
Feng Y; Wang L; Wang M
Biochem Cell Biol; 2018 Oct; 96(5):602-609. PubMed ID: 29590536
[TBL] [Abstract][Full Text] [Related]
15. Distinct Roles of VEGFA and ANGPT2 in Lung Adenocarcinoma and Squamous Cell Carcinoma.
Qin S; Yi M; Jiao D; Li A; Wu K
J Cancer; 2020; 11(1):153-167. PubMed ID: 31892982
[No Abstract] [Full Text] [Related]
16. Forkhead box M1 over-expression and dachshund homolog 1 down-regulation as novel biomarkers for progression of endometrial carcinoma in Egyptian patients.
Hafez AM; Harb OA; Etman WM; Hamed B; Namour AE; Abdelaziz LA
Contemp Oncol (Pozn); 2021; 25(2):107-117. PubMed ID: 34667437
[TBL] [Abstract][Full Text] [Related]
17. [Methylation status of DACH1 gene in esophageal cancer and its clinical significance].
Liu Y; Li J; Ding H; Xu C; Kou X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):1002-1006. PubMed ID: 34625942
[TBL] [Abstract][Full Text] [Related]
18. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
19. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
[TBL] [Abstract][Full Text] [Related]
20. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
